DoMore

DoMore! is a pioneering initiative focused on revolutionizing cancer diagnostics through the application of artificial intelligence (AI). Operating within the healthcare sector, specifically oncology, the project leverages deep convolutional neural networks to improve the accuracy of cancer prognostication. By utilizing advanced 3D modeling techniques, DoMore! provides a comprehensive view of tumor heterogeneity, which is crucial for understanding cancer development and tailoring effective treatment plans.

The primary clients of DoMore! are healthcare institutions, research organizations, and medical professionals who require cutting-edge tools for cancer diagnosis and treatment planning. The project operates in the global healthcare market, addressing a critical need for more precise and personalized cancer care.

DoMore! employs a research-driven business model, funded by grants and partnerships with academic and medical institutions. The project generates value by developing and licensing AI-based diagnostic tools and software, which are then integrated into clinical workflows to enhance patient outcomes.

The initiative was selected as one of the Norwegian Research Council's Lighthouse projects, highlighting its significance in addressing large societal challenges through innovative technology. Led by Institute Director E. Greger Danielsen at the Institute for Cancer Genetics and Informatics at Oslo University Hospital, DoMore! is at the forefront of AI in healthcare.

Keywords: AI, cancer diagnostics, deep learning, 3D modeling, tumor heterogeneity, prognostication, healthcare innovation, oncology, personalized treatment, research-driven.